Ros signaling under metabolic stress: cross-talk between ampk and akt pathway
Next, we must discuss GLP-RA and sympathetic nervous system activation
Single and dual agonists The fundamental difference between these two molecules is that semaglutide is a GLP-1 agonist, i.e., it has a strong structural similarity (95%) with this hormone and specifically activates its receptor, while tirzepatide is a dual agonist, i.e., it has a hybrid structure that allows it to activate both GLP-1 and GIP receptors (Figure 2)
Most protocols begin with 1-2 injections weekly for 4-8 weeks
The tirzepatide with B12 guide confirms this principle with detailed examples
IL-1RA dampens the pro-inflammatory effects of IL-1, preventing excessive inflammation and mitigating neuroinflammatory processes associated with neurological disorders (reviewed in: 39 )